Mode
Text Size
Log in / Sign up
N/A N=86 Randomized Triple-blind Treatment

Low Level Laser Light Therapy and Chronic Neck and Shoulder Pain

Shoulder Pain · Neck Pain · Musculoskeletal Pain · Musculoskeletal Strain · Musculoskeletal Sprain

Enrolled (actual)
86
Serious AEs
0.0%
Results posted
Apr 2013
Primary outcome: Primary: The Number of Participants Whose Self-reported Pain Rating in the Neck and Shoulder Area on the 0-100 Visual Analog Scale (VAS) Decreased by 30% or More From Baseline to One Day After Study Treatment — 5; 28 participants — p=<0.0001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Erchonia PL2000 (Device); Placebo laser (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Erchonia Corporation
Primary completion
Jun 2001

Outcome Measures

OutcomeResultp-value
PRIMARY
The Number of Participants Whose Self-reported Pain Rating in the Neck and Shoulder Area on the 0-100 Visual Analog Scale (VAS) Decreased by 30% or More From Baseline to One Day After Study Treatment
5; 28 <0.0001 sig
PRIMARY
Change in Self-reported Pain Rating in the Neck and Shoulder Area on the 0-100 Visual Analog Scale (VAS)From Baseline to One Day Post-treatment
-4.34; -28.06 <0.0001 sig
SECONDARY
Range of Motion of the Neck and Shoulders
SECONDARY
Muscle Trigger Points of the Cervical Spine

Summary

The purpose of this study was to determine whether the application of low level laser light therapy to the neck and shoulder region is effective in reducing chronic neck and shoulder pain of musculoskeletal origin.

Eligibility Criteria

Inclusion Criteria

  • Location of pain is on the right and/or left side of the neck and/or shoulder and/or the back of the neck.
  • Etiology of pain is osteoarthritis/Degenerative Joint Disorder (DJD); chronic muscle spasms or cervical and thoracic spine sprain strain, determined according to subject medical history, medication use history, previous records review, physical examination of the cervical spine and shoulder.
  • Stage of injury is chronic, having prevailed for longer than 30 days.
  • Degree of Pain self-rating of 50 or greater on the 0-100 Visual Analog Scale (VAS).
  • 18-65 years.

Exclusion Criteria

  • Stage of injury is acute, having prevailed for less than 30 days.
  • Known herniated disc injury.
  • Any other disease or condition that may cause or contribute to the chronic pain condition.
  • Presence of infection or open wound at the treatment areas.
  • Use of steroids or narcotics.
  • Use of over-the-counter (OTC) medication for the relief of pain within the 24-hour period prior to participating in the treatment phase of the study, or prescription medication for the relief of pain within the 48-hour period prior to participating in the treatment phase of the study.
  • pregnant or lactating.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00929305). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search